The antibody cocktail, which is a product jointly developed by Roche and Regeneron, is proven to be effective in treating patients aged 12 years and above, with mild to moderate COVID-19. The antibody cocktail can also be used to treat patients who are at high risk of severe or progressing to severe COVID-19, such as the elderlies and people with obesity or other chronic diseases.

MIAMI - A cocktail of three antibodies has shown promise in preventing Zika virus infection in monkeys, and moves next into trials in humans, researchers said Wednesday.